Clinical Trials in Arizona

Showing 221-240 of 14,395 trials

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

NCT07259317

This is a Phase 2, single-arm study to evaluate the safety and efficacy of relacorilant in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic adenocarcinoma (PDAC).

AdenocarcinomaCarcinoma, Pancreatic Ductal

Corcept Therapeutics60 participantsStarted Jan 2026

Scottsdale, Arizona, United States • Los Angeles, California, United States • Atlanta, Georgia, United States +7 more locations

COMPLETEDPhase 231 miles

Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma

NCT03915444

This is a phase II open-label study evaluating the efficacy and safety of nab-paclitaxel cisplatin, and gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma.

Pancreatic Ductal Adenocarcinoma

HonorHealth Research Institute42 participantsStarted Jul 2019

Scottsdale, Arizona, United States • Miami, Florida, United States • New Orleans, Louisiana, United States +1 more locations

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma

Find Trials by Condition in Arizona

Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Pyruvate Kinase Deficiency Global Longitudinal Registry

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Trial for Reliability of Urodynamics SysTem

A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia

Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies

A Phase 1/2 Study of Anvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

Global Open-Label Extension Study of Del-desiran for the Treatment of DM1

A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of GM1 Gangliosidosis or GM2 Gangliosidosis

A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)

OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis